AU4860900A - Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells - Google Patents

Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells

Info

Publication number
AU4860900A
AU4860900A AU48609/00A AU4860900A AU4860900A AU 4860900 A AU4860900 A AU 4860900A AU 48609/00 A AU48609/00 A AU 48609/00A AU 4860900 A AU4860900 A AU 4860900A AU 4860900 A AU4860900 A AU 4860900A
Authority
AU
Australia
Prior art keywords
cryopreservation
isolation
methods
epithelial cells
therapeutic use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48609/00A
Inventor
Allan L. Goldstein
Valerie W. Hu
Peter D. Prestidge
Jonathan M. Sackier
Gordon Wigginton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LIFEBANK SERVICES LLC
Original Assignee
LIFEBANK SERVICES LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US13774099P priority Critical
Priority to US60137740 priority
Application filed by LIFEBANK SERVICES LLC filed Critical LIFEBANK SERVICES LLC
Priority to PCT/US2000/040052 priority patent/WO2000073421A2/en
Publication of AU4860900A publication Critical patent/AU4860900A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0605Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
AU48609/00A 1999-06-02 2000-06-01 Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells Abandoned AU4860900A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US13774099P true 1999-06-02 1999-06-02
US60137740 1999-06-02
PCT/US2000/040052 WO2000073421A2 (en) 1999-06-02 2000-06-01 Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells

Publications (1)

Publication Number Publication Date
AU4860900A true AU4860900A (en) 2000-12-18

Family

ID=22478856

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48609/00A Abandoned AU4860900A (en) 1999-06-02 2000-06-01 Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells

Country Status (2)

Country Link
AU (1) AU4860900A (en)
WO (1) WO2000073421A2 (en)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1004204B (en) * 1999-09-29 2003-09-05 Νικολαοσ Γερασιμου Λιναρδοσ Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses
US7118845B2 (en) 2000-06-15 2006-10-10 3M Innovative Properties Company Multiphoton photochemical process and articles preparable thereby
EP2292091A1 (en) 2002-02-13 2011-03-09 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
EP2314673B1 (en) 2001-02-14 2013-07-24 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
AU2020902A (en) 2000-12-06 2002-06-18 Robert J Hariri Method of collecting placental stem cells background of the invention
ES2548591T3 (en) 2001-02-14 2015-10-19 Anthrogenesis Corporation Placenta postpartum mammalian use and placental stem cells of the same
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
AT438708T (en) 2001-11-15 2009-08-15 Childrens Medical Center A process for the isolation, expansion and differentiation of fetal stem cells from chorionzotte, amniotic fluid and the placenta, and therapeutic uses thereof
TW200301132A (en) * 2001-12-06 2003-07-01 Sankyo Co Pharmaceutical compositions containing cells derived from human caul
US8062837B2 (en) 2002-02-14 2011-11-22 Stemcyte, Inc. Plasma-depleted, not erythrocyte-depleted, cord blood compositions and method of making
US8048619B2 (en) 2005-06-02 2011-11-01 Stemcyte, Inc. Method of treating a hematopoietic associated disease or disorder with plasma-depleted, but not erythrocyte-depleted cord blood compositions
US7498171B2 (en) 2002-04-12 2009-03-03 Anthrogenesis Corporation Modulation of stem and progenitor cell differentiation, assays, and uses thereof
US20040161419A1 (en) * 2002-04-19 2004-08-19 Strom Stephen C. Placental stem cells and uses thereof
EP1497435A4 (en) * 2002-04-19 2005-07-27 Univ Pittsburgh Placental derived stem cells and uses thereof
US7462448B2 (en) 2002-08-02 2008-12-09 Stratatech Corporation Species specific DNA detection
WO2004047770A2 (en) 2002-11-26 2004-06-10 Anthrogenesis Corporation Cytotherapeutics, cytotherapeutic units and methods for treatments using them
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
US9572840B2 (en) 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
AU2003304250A1 (en) * 2003-06-27 2005-01-13 Universite Laval Method of isolating cells from umbilical cord
CA2530533C (en) 2003-06-27 2015-02-10 Ethicon, Incorporated Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
US20060216821A1 (en) 2004-02-26 2006-09-28 Reliance Life Sciences Pvt. Ltd. Pluripotent embryonic-like stem cells derived from corneal limbus, methods of isolation and uses thereof
US8187875B2 (en) 2004-02-26 2012-05-29 Reliance Life Sciences Pvt. Ltd. Dopaminergic neurons derived from corneal limbus, methods of isolation and uses thereof
JP2006006249A (en) * 2004-06-28 2006-01-12 Hiroshima Univ Method for culturing amnion-derived cell and utilization of the same
BRPI0514387A (en) * 2004-08-16 2008-06-10 Cellres Corp Pte Ltd isolation, cultivation and stem / progenitor cells Uses
US20060222634A1 (en) 2005-03-31 2006-10-05 Clarke Diana L Amnion-derived cell compositions, methods of making and uses thereof
US8871198B2 (en) 2006-03-29 2014-10-28 Stemnion, Inc. Methods related to wound healing
US8153430B2 (en) 2005-03-31 2012-04-10 Stemnion, Inc. Methods related to surgery
RS53210B (en) 2005-10-13 2014-08-29 Anthrogenesis Corporation Immunomodulation using placental stem cells
WO2007046775A1 (en) 2005-10-21 2007-04-26 Cellresearch Corporation Pte Ltd Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
WO2007070870A1 (en) 2005-12-16 2007-06-21 Ethicon, Inc. Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
CA2635253C (en) 2005-12-29 2017-03-14 Anthrogenesis Corporation Placental stem cell populations
KR20080081088A (en) 2005-12-29 2008-09-05 안트로제네시스 코포레이션 Co-culture of placental stem cells and stem cells from a second source
EP1974013A2 (en) * 2005-12-29 2008-10-01 Anthrogenesis Corporation Improved composition for collecting and preserving placental stem cells and methods of using the composition
EP1987133A2 (en) 2006-02-24 2008-11-05 Reliance Life Sciences Pvt., Ltd. Conjunctival tissue system
HUE028796T2 (en) 2006-03-23 2017-01-30 Pluristem Ltd Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
EP2089510A4 (en) 2006-06-28 2010-05-19 Univ New Jersey Med Amnion-derived stem cells and uses thereof
EP2118267B1 (en) 2007-01-17 2017-03-15 Noveome Biotherapeutics, Inc. Novel methods for modulating inflammatory and/or immune responses
KR20150039214A (en) 2007-02-12 2015-04-09 안트로제네시스 코포레이션 Treatment of inflammatory diseases using placental stem cells
WO2009008928A2 (en) 2007-04-13 2009-01-15 Stemnion, Inc. Methods for treating nervous system injury and disease
EP2164505B1 (en) * 2007-05-28 2014-09-17 Monash University Treatment of chronic lung disease
WO2008156659A1 (en) * 2007-06-18 2008-12-24 Children's Hospital & Research Center At Oakland Method of isolating stem and progenitor cells from placenta
US9200253B1 (en) 2007-08-06 2015-12-01 Anthrogenesis Corporation Method of producing erythrocytes
EP2783692B1 (en) 2007-09-28 2019-01-02 Celularity, Inc. Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
CN106214702A (en) 2007-11-07 2016-12-14 人类起源公司 Applicaion of umbilical cord blood in treatment of premature delivery complications
MX2011001990A (en) 2008-08-20 2011-03-29 Anthrogenesis Corp Improved cell composition and methods of making the same.
JP5869342B2 (en) 2008-11-19 2016-02-24 アンスロジェネシス コーポレーション Amnion-derived adherent cells
US10179900B2 (en) 2008-12-19 2019-01-15 DePuy Synthes Products, Inc. Conditioned media and methods of making a conditioned media
EP2411504B1 (en) 2009-03-26 2017-05-10 DePuy Synthes Products, Inc. Human umbilical cord tissue cells as therapy for alzheimer's disease
US8647617B2 (en) 2009-07-13 2014-02-11 Stemnion, Inc. Methods for modulating inflammatory and/or immune responses
WO2011094181A1 (en) 2010-01-26 2011-08-04 Anthrogenesis Corporation Treatment of bone-related cancers using placental stem cells
NZ630009A (en) 2010-04-07 2016-05-27 Anthrogenesis Corp Angiogenesis using placental stem cells
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8840665B2 (en) 2010-06-11 2014-09-23 Liventa Bioscience, Inc. Method of tendon repair with amnion and chorion constructs
CN107828727A (en) 2010-07-13 2018-03-23 人类起源公司 Methods of generating natural killer cells, cell groups acquired thereby and uses of same
WO2012092485A1 (en) 2010-12-31 2012-07-05 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory rna molecules
WO2012166844A2 (en) 2011-06-01 2012-12-06 Anthrogenesis Corporation Treatment of pain using placental stem cells
US20140294840A1 (en) 2011-11-30 2014-10-02 University Of Bremen Expression of mirnas in placental tissue
AU2012358810B2 (en) 2011-12-23 2018-03-15 DePuy Synthes Products, Inc. Detection of human umbilical cord tissue-derived cells
US10047345B2 (en) 2012-02-13 2018-08-14 Gamida-Cell Ltd. Culturing of mesenchymal stem cells with FGF4 and nicotinamide
US8961617B2 (en) 2012-03-08 2015-02-24 Liventa Bioscience, Inc. Amnion and chorion constructs and uses thereof in abdominal surgery
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
JP2016506968A (en) 2013-02-05 2016-03-07 アントフロゲネシス コーポレーション Placenta-derived natural killer cells
EP3019186A4 (en) * 2013-07-12 2017-03-29 Patrick J. Casey Method for the harvesting, processing, and storage of proteins from the mammalian feto-placental unit and use of such proteins in compositions and medical treatment
CN103725643B (en) * 2013-12-30 2015-12-30 厦门大学 A method of constructing tissue engineering corneal endothelium
CN103966159B (en) * 2014-02-13 2015-08-05 天津和泽干细胞科技有限公司 Human placenta cells and pluripotent stem cells Stem library construction method
CN106566798A (en) * 2016-11-08 2017-04-19 华南生物医药研究院 Method for getting amniotic epithelial stem cells and kit

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD225440B1 (en) * 1984-03-27 1988-09-14 Adw Ddr Cell culture medium
US4975365A (en) * 1987-05-12 1990-12-04 The John Hopkins University Assay for measuring DNA cell repair potential
GB8803697D0 (en) * 1988-02-17 1988-03-16 Deltanine Research Ltd Clinical developments using amniotic membrane cells
US5340740A (en) * 1992-05-15 1994-08-23 North Carolina State University Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process
US6117676A (en) * 1995-07-27 2000-09-12 Srl, Inc. Transfected human amniotic cells and method for producing a gene product
JP3806189B2 (en) * 1995-07-27 2006-08-09 株式会社エスアールエル Process for the preparation of gene transfer methods and gene therapeutic cells to human amniocytes
DE69726054D1 (en) * 1996-01-23 2003-12-18 Srl Inc Cells for treatment of dementia
US6152142A (en) * 1997-02-28 2000-11-28 Tseng; Scheffer C. G. Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries

Also Published As

Publication number Publication date
WO2000073421A3 (en) 2001-04-26
WO2000073421A2 (en) 2000-12-07

Similar Documents

Publication Publication Date Title
AU781501C (en) Anti-alphavbeta3recombinant human antibodies, nucleic acids encoding same and methods of use
AU751064C (en) Antibodies against human CD40
AU2001231095A1 (en) System for organ and tissue preservation and hypothermic blood substitution
AU2782499A (en) Isolated stromal cells for use in the treatment of diseases of the central nervous system
AU2002239665A1 (en) Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
AU5757100A (en) Methods and devices for cell culturing and organ assist systems
AU3149300A (en) Fasteners and methods of making fasteners
AU2466099A (en) Pharmaceutically active compounds and methods of use thereof
AU2002251935A1 (en) Post-partum mammalian placenta, its use and placental stem cells therefrom
AU2609901A (en) Antimicrobial compositions and methods of use
AU2001295490A1 (en) Antibodies to human IL-1beta
AU3867400A (en) Methods of using bioelastomers
AU2002366306A1 (en) Animal breeding system and utilization of the system
AU4300701A (en) Methods and compositions for administration of therapeutic reagents
AU1219100A (en) Method and kit for rapid preparation of autologous tissue medical devices
AU7735200A (en) Treatment of tissue by application of energy and drugs
AU2111199A (en) Benzenesulfonamides and benzamides as therapeutic agents
AU3885600A (en) Splint bandage and method
AU6608900A (en) Thermal quenching of tissue
IL200540A (en) Tissue matrices comprising placental stem cells and methods of making them
AU2002319054A1 (en) Multipotent stem cells from peripheral tissues and uses thereof
AU2002315095A1 (en) Electroporation microneedle and methods for its use
AU5963900A (en) Muteins of bilin-binding protein
AU4837300A (en) Antimicrobial theta defensins and methods of using same
AU2002226668A1 (en) Methods, systems and devices for in vivo electrochemical production of therapeutic agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase